What is the role of CTCA prior to angiography in patients with previous CABG?
By Dr Jonathan Shurlock, edited by Dr. Ahmed El-Medany At TCT 2022 in the late-breaking clinical science session Dr Daniel Jones presented the findings of…
View More What is the role of CTCA prior to angiography in patients with previous CABG?
The PROTECTED TAVR trial – what do the findings show?
By Dr Jonathan Shurlock, edited by Dr. Ahmed El-Medany Since its findings were presented at TCT 2022 the results of the PROTECTED TAVR trial have…
View More The PROTECTED TAVR trial – what do the findings show?
Is there a relationship between artificial sweetener consumption and cardiovascular disease?
By Dr. Jonathan Shurlock, edited by Dr. Ahmed El-Medany A large group led by PhD candidate Charlotte Debras have published their findings from the NutriNet-Santé…
View More Is there a relationship between artificial sweetener consumption and cardiovascular disease?
Fewer than 1-in-10 “statin-related” muscle pains are caused by statins
By Dr. Timothy Swinn, edited by Dr. Ahmed El-Medany A recent meta-analysis published in the Lancet[1] has concluded that fewer than 1 in 15 muscle…
View More Fewer than 1-in-10 “statin-related” muscle pains are caused by statins
Aspirin or P2Y12 inhibitor for coronary artery disease?
By Dr. Jonathan Shurlock, edited by Dr. Ahmed El-Medany Professor Marco Valgimigli presented the findings of the PANTHER analysis at the 2022 ESC congress. Currently…
View More Aspirin or P2Y12 inhibitor for coronary artery disease?
AVDOR: The resurrection of acetazolamide
By Dr. Aswin Babu, edited by Dr. Ahmed El-Medany At the most recent European Society of Cardiology (ESC) congress, the results of the AVDOR (Acetazolamide…
View More AVDOR: The resurrection of acetazolamide
DELIVER trial: Dapagliflozin reduces hospitalisation or cardiovascular death in patients with HFpEF and HFmrEF
By Dr. Timothy Swinn, edited by Dr. Ahmed El-Medany Recent evidence from the DELIVER trial[1], published in the New England Journal of Medicine and presented…
View More DELIVER trial: Dapagliflozin reduces hospitalisation or cardiovascular death in patients with HFpEF and HFmrEF
REVIVED-BCIS2: Cardiologists’ reactions around the Globe
Collated by Dr. Oliver Jones, edited by Dr. Ahmed El-Medany The bombshell results of REVIVED-BCIS landed this week at ESC 2022. BCS Heartbeat has reactions…
View More REVIVED-BCIS2: Cardiologists’ reactions around the Globe
SECURE Polypill trial: New life for an old idea
By Dr. Oliver Jones, edited by Dr. Ahmed El-Medany Key points: A polypill containing aspirin, ramipril, and atorvastatin was effective in reducing a composite of…
View More SECURE Polypill trial: New life for an old idea
PCI no better than OMT in severe Ischaemic Cardiomyopathy: REVIVED-BCIS2
By Dr. Ahmed El-Medany Key points: PCI does not reduce all-cause mortality or heart failure hospitilisation ins patients with severe LVSD and extensive CAD, and…
View More PCI no better than OMT in severe Ischaemic Cardiomyopathy: REVIVED-BCIS2